Keep Antibiotics Working (KAW) is on the Food and Drug Administration’s (FDA) case again about the growth promotion marketing loophole for antibiotics. Last May, KAW alerted FDA to their concerns that drug manufacturer Novartis was using promotional materials for a feed additive used to treat dysentery and pneumonia and enteric
Continue Reading Antibiotics Coalition Wants Drug Companies to Stop Growth Promotion Marketing